Johnson & Johnson’s Janssen Pharmaceutical Cos. has advanced its COVID-19 vaccine candidate JNJ-78436735 into a Phase III trial designed to assess the safety and effectiveness of the single-dose vaccine compared with placebo in up to 60,000 volunteers across three continents.
A giant virus that replicates in the human pathogen single-celled organism Naegleria fowleri has been discovered.
Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML.
Researchers discovered in mice that conditions such as diabetes diagnosed in people with spinal cord injuries, can be linked to abnormal post-injury neuronal activity.
New tools and platforms to accelerate vaccine development and manufacturing are in high demand and short supply. InDevR’s VaxArray Platform is a microarray-based system for…
Two independent research teams have successfully regenerated mouse brain circuits in mice using neurons grown from rat stem cells.
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
And there are benefits of plant cell expression systems, notably their impact on the cost of goods sold (COGS).
A British-based cell therapy company is using smart operations to streamline its viral vector processing.
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
Prodigiosin applications extend from manufacturing pigment and environmental-control agent to antibiotic and potential oncology drug.
